LEAP2 and obesity disorder: Due to the role of ghrelin in cognition, its increased inhibition by upregulated LEAP-2 levels may be a crucial link between obesity and cognitive dysfunction, implicating a potentially critical role of the LEAP-2 peptide in communication between the brain and gut in both metabolic and cognitive control.